Plus Therapeutics Inc. (PSTV)
NASDAQ: PSTV
· Real-Time Price · USD
0.63
0.09 (16.19%)
At close: Aug 15, 2025, 3:59 PM
0.57
-9.97%
After-hours: Aug 15, 2025, 07:59 PM EDT
Plus Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -27.12M | -12.98M | -12.88M | -13.23M | -11.77M | -13.32M | -15.16M | -17.16M | -20.96M | -20.27M | -18.77M | -17.28M | -14.79M | -13.4M | -12.83M | -10.84M | -9.87M |
Depreciation & Amortization | 683K | 723K | 685K | 698K | 684K | 685K | 779K | 758K | 700K | 660K | 630K | 493K | 457K | 398K | 362K | 360K | 365K |
Stock-Based Compensation | 552K | 550K | 563K | 586K | 575K | 569K | 558K | 539K | 566K | 606K | 657K | 708K | 679K | 606K | 523K | 437K | 342K |
Other Working Capital | 3.45M | 1.9M | 715K | 2.21M | -1.68M | -1.5M | -4.26M | -4.11M | -2.41M | -566K | 78K | -417K | -285K | -914K | -22K | -1.97M | -2.05M |
Other Non-Cash Items | 10.4M | -2.07M | -1.89M | -825K | 397K | 448K | 388K | 382K | 470K | 506K | 711K | 840K | 831K | 877K | 670K | 715K | 761K |
Deferred Income Tax | n/a | n/a | -121K | -121K | -121K | -121K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 3.38M | 3.22M | 2.42M | 2.95M | -1.33M | -1.12M | 235K | 458K | 4.34M | 5.53M | 3.41M | 3.85M | 1.68M | 1.24M | 396K | -1.6M | -1.53M |
Operating Cash Flow | -12.21M | -10.55M | -11.22M | -9.94M | -11.57M | -12.85M | -13.2M | -15.03M | -14.89M | -12.97M | -13.36M | -11.39M | -11.15M | -10.28M | -10.88M | -10.93M | -9.94M |
Capital Expenditures | -654K | -691K | -722K | -718K | -103K | -160K | -129K | -152K | -279K | -759K | -758K | -779K | -637K | -144K | -190K | -150K | -566K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -15.27M | -15.59M | -7.14M | -3.5M | -324K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 15.7M | 12.17M | 3.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -515K | -545K | -545K | -545K | n/a | n/a | 117K | 117K | 117K | -250K | -355K | -305K | -305K | 62K | 50K | n/a | -400K |
Investing Cash Flow | -189K | -4.11M | -4.22M | -4.22M | -427K | -160K | -129K | -152K | -279K | -759K | -746K | -717K | -575K | -82K | -140K | -150K | -566K |
Debt Repayment | -3.3M | 3.29M | -1.11M | -1.51M | -1.61M | -1.61M | -1.61M | -1.61M | -1.61M | -1.61M | -1.47M | -1.07M | -672K | -276K | -32K | -74K | -5.41M |
Common Stock Repurchased | 374K | n/a | -126K | -500K | -500K | -126K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.83M | 2.92M | 2.92M | 10.56M | -1K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.02M | 2.03M | 2.75M | 3.12M |
Financial Cash Flow | 19.37M | 6.19M | 5.66M | 8.18M | 2.18M | 3.44M | 4.07M | 7.98M | 6.65M | 13.45M | 13.09M | 13.04M | 18.52M | 20.42M | 24.67M | 18.97M | 8.89M |
Net Cash Flow | 6.97M | -8.48M | -9.78M | -5.98M | -9.82M | -9.57M | -9.26M | -7.2M | -8.52M | -280K | -1.01M | 929K | 6.79M | 10.05M | 13.65M | 7.89M | -1.61M |
Free Cash Flow | -12.87M | -11.24M | -11.95M | -10.66M | -11.67M | -13.01M | -13.33M | -15.18M | -15.17M | -13.73M | -14.12M | -12.17M | -11.79M | -10.42M | -11.07M | -11.08M | -10.5M |